Muscular Side Effects of Statins

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-200208000-00001PMID 12131545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

  2004cited by this paper
• Coenzyme Q10 and coronary artery disease

  2004cited by this paper
• Flu-like response on statins.

  2002cited by this paper
• Increase of isoprostane 8-epi-PGF2 αafter restarting smoking

  2001cited by this paper
• The Treatment of Coronary Heart Disease: An Update

  2001cited by this paper
• Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study

  2001influential reference
• Increased Isoprostane 8-epi-PGF2A in Statin-Induced Myopathy

  2001cited by this paper
• Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking.

  2001cited by this paper
• Essential fatty acids as possible mediators of the actions of statins.

  2001cited by this paper
• The effect of pravastatin and atorvastatin on coenzyme Q10.

  2001cited by this paper
• Isoprostane 8‐epi‐PGF2α is frequently increased in patients with muscle pain and/or CK‐elevation after HMG‐Co‐enzyme‐A‐reductase inhibitor therapy

  2001cited by this paper
• Advances in Prostaglandin and Leukotriene Research

  2001cited by this paper
• Statin induced myopathy does not show up in MIBI scintigraphy

  2001cited by this paper
• Increased lipid peroxidation in a patient with CK-elevation and muscle pain during statin therapy.

  2000cited by this paper
• Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation?

  2000cited by this paper
• Evaluation of skeletal muscle metabolism and response to erythropoietin treatment in patients with chronic renal failure using 99Tcm-sestamibi leg scintigraphy

  2000cited by this paper
• ACE-inhibitor rather than HMG-co-enzyme-A-reductase inhibits causative for CK-elevation? A case report.

  2000influential reference
• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment.

  1999cited by this paper
• Increased lipid peroxidation in patients with rhabdomyolysis.

  1999cited by this paper
• F2-isoprostane excretion rate and diurnal variation in human urine.

  1999cited by this paper
• Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.

  1999cited by this paper
• Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia.

  1999cited by this paper
• The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.

  1997cited by this paper
• Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.

  1997cited by this paper
• Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia.

  1997cited by this paper
• Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia.

  1997cited by this paper
• New lipid lowering drugs and new effects of old drugs.

  1997cited by this paper
• Lovastatin increases exercise-induced skeletal muscle injury.

  1997cited by this paper
• The isoprostanes. Current knowledge and directions for future research.

  1996cited by this paper
• Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

  1996cited by this paper
• Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.

  1995cited by this paper
• Pravastatin-associated myopathy. Report of a case.

  1995cited by this paper
• Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin.

  1995cited by this paper
• Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

  1995cited by this paper
• Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin.

  1995cited by this paper
• Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors.

  1994cited by this paper
• Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

  1993cited by this paper
• Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study

  1993cited by this paper
• Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits

  1993cited by this paper
• Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation.

  1992cited by this paper
• Massive rhabdomyolysis and simvastatin.

  1992cited by this paper
• Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

  1991cited by this paper
• Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

  1990cited by this paper
• Rhabdomyolysis secondary to lovastatin therapy.

  1990cited by this paper
• Lovastatin decreases coenzyme Q levels in rats.

  1990cited by this paper
• Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.

  1988cited by this paper
• Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.

  1988cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Isolation of a quinone from beef heart mitochondria.

  1957cited by this paper

• Comparative Evaluation of Bone Regeneration in Third Molar Extraction Using Simvastatin Powder And Simvastatin Gel—A Split-Mouth Study

  2025cites this paper
• Enhanced long-acting simvastatin delivery via effervescent powder-carrying hollow microneedles and nanocrystal-loaded microneedles.

  2024cites this paper
• Nanomedicine marvels: crafting the future of cancer therapy with innovative statin nano-formulation strategies

  2024cites this paper
• The Great Cholesterol Quandary and Global Consciousness Awakening

  2023cites this paper
• Socket Preservation Using Atorvastatin versus Plasma Rich Fibrin: A Randomized Clinical and Histomorphometric Controlled Trial

  2022cites this paper
• Antihyperlipidemic activity of isoflavones

  2021cites this paper
• Fluvastatin suppresses the proliferation, invasion, and migration and promotes the apoptosis of endometrial cancer cells by upregulating Sirtuin 6 (SIRT6)

  2021cites this paper
• Bone Regeneration : A Systematic Review

  2020cites this paper
• Calcium Phosphate Carrying Simvastatin Enhances Bone Regeneration: A Systematic Review.

  2020cites this paper
• Alleviation of Simvastatin-Induced Myopathy in Rats by the Standardized Extract of Ginkgo Biloba (EGb761): Insights into the Mechanisms of Action

  2020cites this paper
• Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review

  2020cites this paper
• Use of Statins as Lipid Lowering Agent in Hypercholesterolemia in a Tertiary Care Hospital: A Descriptive Cross-sectional Study

  2020cites this paper
• Muscle Toxicity of Drugs: When Medication Turns Physiology into Pathophysiology.

  2019cites this paper
• Exercise training adaptations in metabolic syndrome individuals on chronic statin treatment.

  2019cites this paper
• Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non–Small Cell Lung Carcinogenesis

  2019cites this paper
• Mitophagy protects against statin‐mediated skeletal muscle toxicity

  2019cites this paper
• Targeting cellular cholesterol for anticancer therapy

  2019cites this paper
• Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy.

  2019cites this paper
• Statins: Rationale, Mode of Action, and Side Effects

  2019cites this paper
• Statins in nonsurgical and surgical periodontal therapy. A systematic review and meta‐analysis of preclinical in vivo trials

  2018cites this paper
• Statin and Fibrate‐Induced Dichotomy of Mitochondrial Function

  2018cites this paper
• Impact du genre sur la survenue d’effets indésirables sous statines en médecine générale

  2018cites this paper
• Oxidative stress as a possible mechanism of statin-induced myopathy

  2018cites this paper
• Dill-normalized liver lipid accumulation, oxidative stress, and low-density lipoprotein receptor levels in high cholesterol fed hamsters

  2018cites this paper
• Carbon Nanodot Cellular Uptake and Modulation of Tumor Necrosis Factor-Alpha-Induced Endothelial Dysfunction

  2018cites this paper
• Ethyl acetate extract of crabapple fruit is the cholesterol-lowering fraction

  2017cites this paper
• Effect of ezetimibe on plasma adipokines: a systematic review and meta‐analysis

  2017cites this paper
• SYSTEMATIC REVIEW AND META – ANALYSIS Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis

  2017cites this paper
• Detrimental Effect of Statin Therapy in Women With Fibromyalgia

  2017cites this paper
• Risk of Late-Onset Alzheimer's Disease by Plasma Cholesterol: Rational In Silico Drug Investigation of Pyrrole-Based HMG-CoA Reductase Inhibitors

  2017cites this paper
• Regulation of cardiometabolic risk factors by dietary Toll-like receptor stimulants

  2017cites this paper
• The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy

  2016cites this paper
• Muscle- and skeletal-related side-effects of statins: tip of the iceberg?

  2016cites this paper
• Can social media data lead to earlier detection of drug‐related adverse events?

  2016cites this paper
• The use of statin drug therapy for primary prevention of cardiovascular disease in primary care: a retrospective cohort study

  2016cites this paper
• Simvastatin, dosage and delivery system for supporting bone regeneration, an update review

  2016cites this paper
• The Effect of AST-120 on Hepatic Metabolism and Transport in Chronic Kidney Disease

  2016cites this paper
• An insight into statin use and its association with muscular side effects in clinical practice

  2015cites this paper
• How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease

  2015cites this paper
• A systems engineering approach to coronary heart disease

  2015cites this paper
• Novel applications of statins for bone regeneration.

  2015cites this paper
• The impact of physical activity on statin-associated skeletal muscle myopathy

  2015cites this paper
• A novel anabolic agent: a simvastatin analogue without HMG-CoA reductase inhibitory activity.

  2014cites this paper
• Mechanisms and assessment of statin‐related muscular adverse effects

  2014cites this paper
• The Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations

  2014cites this paper
• Red yeast rice and coenzyme Q 10 as safe alternatives to

  2014cites this paper
• Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes

  2014cites this paper
• Impact of physical activity on immune function and inflammation in the elderly

  2014cites this paper
• Incident user cohorts for assessing medication cost-offsets.

  2014cites this paper
• Regulation of legumain in human cells

  2014cites this paper
• Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.

  2014cites this paper
• Computational models for mining online drug reviews

  2014cites this paper
• Anti-hyperlipidemic effect of flavone-rich Belamcanda chinensis (L.) DC. (Iridaceae) leaf extract in ICR mice fed high-fat diet

  2014cites this paper
• Silençage du gène ApoB codant pour l’apolipoprotéine B responsable de l’athérosclérose, in vitro et in vivo, à l’aide des nanoparticules chitosane/siARN-ApoB

  2014cites this paper
• Muscle pain and use of statin drugs.

  2014cites this paper
• Downloa Statin Treatment Simvastatin Impairs Exercise Training Adaptations

  2013cites this paper
• Discontinuation of statin therapy due to muscular side effects: a survey in real life.

  2013cites this paper
• Simvastatin Impairs Exercise Training Adaptations FOCUS ISSUE: CARDIOMETABOLIC RISK

  2013cites this paper
• Effects of ezetimibe on serum polyunsaturated fatty acids in patients with coronary artery disease.

  2013cites this paper
• Simvastatin impairs exercise training adaptations.

  2013cites this paper
• Effect of garlic on serum lipids: an updated meta-analysis.

  2013cites this paper
• IMPACT OF THE HEALTH IT UP INTERVENTION ON PLASMA LIPIDS AND GLUCOSE IN COLLEGE STUDENTS

  2012cites this paper
• Analgesic drug use associated with statin prescription--a cross-sectional study in primary care settings.

  2012cites this paper
• The Effects of Noni (Morinda citrifolia L.) Fruit Juice on Cholesterol Levels: A Mechanistic Investigation and An Open Label Pilot Study

  2012cites this paper
• Not a graves' situation.

  2011cites this paper
• Drugs causing muscle disease.

  2011cites this paper
• Statin myopathy: A common dilemma not reflected in clinical trials

  2011cites this paper
• Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.

  2011cites this paper
• ASSOCIAÇÃO ENTRE MIOPATIA INDUZIDA POR ESTATINAS E EXERCÍCIO FÍSICO

  2011cites this paper
• Garlic, Chocolate, or Tomatoes for (Pre-) Hypertension?

  2011cites this paper
• Prevalence and risk factors of muscle complications secondary to statins

  2011cites this paper
• Regarding "Optimal statin type and dosage for vascular patients".

  2011cites this paper
• Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials.

  2011cites this paper
• Statin‐associated changes in skeletal muscle function and stress response after novel or accustomed exercise

  2011cites this paper
• Statin-associated skeletal muscle damage and its interactions with novel or accustomed exercise

  2011cites this paper
• [Current views on lipid metabolism: statin-induced myopathy].

  2010cites this paper
• Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.

  2010cites this paper
• Dietary Fat Intake: Promotion of Disease in Carotid Artery Disease: Lipid Lowering Versus Side Effects of Statins

  2010cites this paper
• Statin‐associated myopathy and its exacerbation with exercise

  2010cites this paper
• Lipidstoffwechsel aktuell: statininduzierte Myopathien

  2010cites this paper
• Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 Patients

  2010cites this paper
• Approach to the patient who is intolerant of statin therapy.

  2010cites this paper
• A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.

  2010cites this paper
• Coenzyme Q10 Supplementation for the Treatment of Statin Induced Myalgia

  2010cites this paper
• Drug-induced myopathies.

  2009cites this paper
• Physical activity in statin-treated patients.

  2009cites this paper
• Statin-associated focal myositis.

  2009cites this paper
• Association between statin-associated myopathy and skeletal muscle damage

  2009influential citation
• Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.

  2009cites this paper
• Is general practice the optimal setting for the recognition of statin-induced myotoxicity?

  2009cites this paper
• Potential New Therapeutic Agents: Effects on HIV Replication and Viral Escape

  2009cites this paper
• Concerns about efficacy and safety of statins in the prevention of stroke

  2009cites this paper
• Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing

  2009cites this paper
• Do statins interfere with physical activity in the treatment of metabolic syndrome?

  2008cites this paper
• Statins: under investigation for increasing bone mineral density and augmenting fracture healing

  2008cites this paper
• New insights into mechanisms of statin-associated myotoxicity.

  2008cites this paper
• Suppression of Serum Cholesterol Levels in Mice by Adzuki Bean Polyphenols

  2008cites this paper
• Statins: under investigation for increasing bone mineral density and augmenting fracture healing.

  2008cites this paper
• Detrimental effect of statin therapy in women with fibromyalgia.

  2008cites this paper
• Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

  2008cites this paper